Mesoblast Limited (MESO) Stock Forecast
MESO analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.33 / 5 from 3 analysts
- Price target
- $37.00 average of analyst targets
- Upside to target
- +178.6% from the latest close
- Next earnings
- —
- 52-week range
- $13.19 – $20.96
MESO analyst ratings
3 analystsNumber of analysts at each rating.
MESO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MESO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.08 | −$0.08 | −$0.08 | — | — | 1 |
| Next quarter (Dec '26) | −$0.07 | −$0.07 | −$0.07 | — | — | 1 |
| Current fiscal year (FY2027) | −$0.06 | −$0.12 | $0.01 | −$0.44 | +87.6% | 2 |
| Next fiscal year (FY2028) | $0.46 | $0.36 | $0.55 | −$0.06 | +927.3% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MESO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $54.9M | $54.9M | $54.9M | — | 1 |
| Next quarter (Dec '26) | $57.2M | $57.2M | $57.2M | +33.4% | 1 |
| Current fiscal year (FY2027) | $267.6M | $209.3M | $361.2M | +59.5% | 6 |
| Next fiscal year (FY2028) | $424.8M | $274.2M | $725.7M | +58.7% | 6 |
MESO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MESO revenue: reported and forecast
MESO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.08 | $0.08 | $0.08 | $0.08 | −$0.08 | −200.0% | 0 up · 1 down |
| Next quarter (Dec '26) | $0.08 | $0.08 | $0.08 | $0.08 | −$0.07 | −187.5% | 0 up · 1 down |
| Current fiscal year (FY2027) | −$0.07 | −$0.06 | −$0.06 | −$0.06 | −$0.06 | −21.4% | 1 up · 0 down |
| Next fiscal year (FY2028) | $0.40 | $0.40 | $0.42 | $0.42 | $0.46 | +13.7% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MESO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MESO beat in 10 of 12.
What analysts expect from MESO
3 analysts cover Mesoblast; their consensus rating is buy (4.33 on a 1–5 scale, where 5 is a strong buy). The average price target is $37.00, 178.6% above the latest close of $13.28. Analysts expect earnings of −$0.06 per share for FY2027, +87.6% from a year earlier. For FY2028 the average estimate is $0.46 per share on revenue of $424.8 million. Mesoblast beat the EPS estimate in 10 of the last 12 quarters.
Related: MESO income statement, MESO key metrics, MESO chart. See the MESO stock overview for the latest quote and news.
MESO forecast FAQ
What is Mesoblast's price target?
The average analyst price target for Mesoblast is $37.00, 178.6% above the latest close of $13.28.
Is Mesoblast a buy, hold or sell?
Of 3 analysts covering Mesoblast, 1 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Mesoblast's EPS forecast?
Analysts forecast −$0.06 per share for FY2027 (range −$0.12 to $0.01); for FY2028 the estimate is $0.46.
What is Mesoblast's revenue forecast?
The average revenue estimate for FY2027 is $267.6 million, growth of 59.5%; for FY2028 it is $424.8 million.
Does Mesoblast usually beat earnings estimates?
Mesoblast reported EPS at or above the analyst estimate in 10 of the last 12 quarters.